Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 1;190(8):1632-1642.
doi: 10.1093/aje/kwaa270.

Study Designs for Extending Causal Inferences From a Randomized Trial to a Target Population

Study Designs for Extending Causal Inferences From a Randomized Trial to a Target Population

Issa J Dahabreh et al. Am J Epidemiol. .

Abstract

In this article, we examine study designs for extending (generalizing or transporting) causal inferences from a randomized trial to a target population. Specifically, we consider nested trial designs, where randomized individuals are nested within a sample from the target population, and nonnested trial designs, including composite data-set designs, where observations from a randomized trial are combined with those from a separately obtained sample of nonrandomized individuals from the target population. We show that the counterfactual quantities that can be identified in each study design depend on what is known about the probability of sampling nonrandomized individuals. For each study design, we examine identification of counterfactual outcome means via the g-formula and inverse probability weighting. Last, we explore the implications of the sampling properties underlying the designs for the identification and estimation of the probability of trial participation.

Keywords: causal inference; generalizability; randomized trials; transportability.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sampling designs for studies extending inferences from a randomized trial to a target population. For detailed descriptions of notation, see the main text. Briefly, X denotes baseline covariates, S the trial participation indicator, and D the indicator for sampling into the study sample. The dashed box around D = 0 denotes the fact that covariate data may not be available from this subset and that in nonnested trial designs the size of the subset may be unknown.

References

    1. Keiding N, Louis TA. Perils and potentials of self-selected entry to epidemiological studies and surveys. J R Stat Soc Ser A Stat Soc. 2016;179(2):319–376.
    1. Hernán MA. Discussion of “perils and potentials of self-selected entry to epidemiological studies and surveys”. J R Stat Soc Ser A Stat Soc. 2016;179(2):346–347.
    1. Dahabreh IJ, Hernán MA. Extending inferences from a randomized trial to a target population. Eur J Epidemiol. 2019;34(8):719–722. - PubMed
    1. Cole SR, Stuart EA. Generalizing evidence from randomized clinical trials to target populations: the ACTG 320 trial. Am J Epidemiol. 2010;172(1):107–115. - PMC - PubMed
    1. Buchanan AL, Hudgens MG, Cole SR, et al. Generalizing evidence from randomized trials using inverse probability of sampling weights. J R Stat Soc Ser A Stat Soc. 2018;181(4):1193–1209. - PMC - PubMed

Publication types